| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Catherine Levene is Director at PBI. Catherine Levene's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $272K at current prices.
Net of sales, the PBI filings show accumulation of 200 shares.
Catherine Levene has 6 Form 4 filings on record from November 2024 to May 2026, all as Director at Pitney Bowes (PBI), 2024–2026.
The 7 reported transactions were 4 option or other derivative awards, 2 option exercises and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $2K and no sales.
The only open-market purchase was 200 shares of PBI at an average $9.37 on May 9, 2025, about $2K. Twelve months later PBI was up 69%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | PBI Pitney Bowes Inc /de/ | Director | Buy | 200 | $9.37 | $1,873.10 | New | +20.6% | +69.2% |